IQVIA (IQV): are the analysts right?

IQVIA · Health Care · ref. ETF XLV · 62 calls · price $208.23
What the company does: IQVIA fournit des services de recherche clinique et des services d'intelligence sanitaire à l'industrie des sciences de la vie.
📈 1-year price
$208.23+26.6% over range
Jul 8, 25low $156.66 · high $244.29Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
83% recommend buying · 12 analysts

🎯 Analyst price target on IQV

High target · 2 analysts$255+22.5%
Median target · 12 analysts$220.5+5.9%
Low target · 1 analyst$185-11.2%
Current price$208.23

🗳️ The analyst consensus

Analyst breakdown · 12 (6 months)
Strong Buy0%
Buy83%
Hold17%
Sell0%
Strong Sell0%

✅ Historical analyst reliability on IQV

Most reliable analysts on IQV (% profitable · 365j · ≥2 calls)
Mizuho 100% +14.3% 2
JP Morgan 50% +2.3% 2
Truist Securities 25% -5.7% 12

📊 What $1,000 invested in IQVIA would be worth

In short — $1,000 invested in IQVIA 10 years ago would be worth $2,814 today, i.e. +11%/yr on average. Best year: 2021 (+57%), worst: 2022 (-27%). Price performance, excluding dividends.

If I'd invested $1,000 in IQVIA

InvestmentWorth todayGain
1 years ago$983-2%
3 years ago$943-6%
5 years ago$1,078+8%
10 years ago$2,814+181%
since inception (2013)$4,540+354%

Return by year (IQVIA)

YearReturn$1,000 invested at year start
2026 (YTD)-14%$857 (-14%)
2025+15%$983 (-2%)
2024-15%$835 (-16%)
2023+13%$943 (-6%)
2022-27%$685 (-32%)
2021+57%$1,078 (+8%)
2020+16%$1,251 (+25%)
2019+33%$1,663 (+66%)
2018+19%$1,974 (+97%)
2017+29%$2,541 (+154%)
2016+11%$2,814 (+181%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on IQV

Baird
Jul 1, 26
▲ Outperform · 🎯$249
Price at call : $203.2 — upside +23%
Today : $208.23 — upside +20%
🎯 on IQV : no call matured yet · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Jul 1, 27
■ Equal-Weight neutral · not a buy · 🎯$200
Price at call : $170.67 — gap to target +17%
Today : $208.23 — gap to target -4%
🎯 on IQV : 0% (1 call matured) · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Jun 17, 27
▲ Outperform · 🎯$185
Price at call : $168.98 — upside +9%
Today : $208.23 — upside -11%
🎯 on IQV : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Apr 8, 27
TD Cowen
Mar 9, 26
▲ Buy · 🎯$213
Price at call : $170.93 — upside +25%
Today : $208.23 — upside +2%
🎯 on IQV : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Mar 9, 27
Barclays
Mar 6, 26
▲ Overweight · 🎯$210
Price at call : $174.49 — upside +20%
Today : $208.23 — upside +1%
🎯 on IQV : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Mar 6, 27
RBC Capital
Mar 3, 26
▲ Outperform · 🎯$221
Price at call : $177.88 — upside +24%
Today : $208.23 — upside +6%
🎯 on IQV : 0% (1 call matured) · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Mar 3, 27
▲ Buy · 🎯$245
Price at call : $165.62 — upside +48%
Today : $208.23 — upside +18%
🎯 on IQV : 25% (12 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Feb 19, 27
JP Morgan
Feb 6, 26
▲ Overweight · 🎯$225
Price at call : $192.67 — upside +17%
Today : $208.23 — upside +8%
🎯 on IQV : 50% (2 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Feb 6, 27
Citigroup
Feb 6, 26
■ Neutral neutral · not a buy · 🎯$200
Price at call : $192.67 — gap to target +4%
Today : $208.23 — gap to target -4%
🎯 on IQV : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Feb 6, 27
UBS
Feb 6, 26
▲ Buy · 🎯$240
Price at call : $192.67 — upside +25%
Today : $208.23 — upside +15%
🎯 on IQV : 100% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Feb 6, 27
Jefferies
Feb 6, 26
▲ Buy · 🎯$255
Price at call : $192.67 — upside +32%
Today : $208.23 — upside +22%
🎯 on IQV : no call matured yet · 📊 on Health : 50.5% · +4.5% (376 calls)
in progress (365j)
matures : Feb 6, 27
Stifel
Feb 6, 26
▲ Buy · 🎯$220
Price at call : $192.67 — upside +14%
Today : $208.23 — upside +6%
🎯 on IQV : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Feb 6, 27
Barclays
Feb 6, 26
■ Equal-Weight neutral · not a buy · 🎯$210
Price at call : $192.67 — gap to target +9%
Today : $208.23 — gap to target +1%
🎯 on IQV : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Feb 6, 27
TD Cowen
Jan 22, 26
■ Hold neutral · not a buy · 🎯$245
Price at call : $235.31 — gap to target +4%
Today : $208.23 — gap to target +18%
🎯 on IQV : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Jan 22, 27
▲ Buy · 🎯$290
Price at call : $242.41 — upside +20%
Today : $208.23 — upside +39%
🎯 on IQV : 25% (12 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Jan 8, 27
UBS
Jan 8, 26
▲ Buy · 🎯$280
Price at call : $242.41 — upside +16%
Today : $208.23 — upside +34%
🎯 on IQV : 100% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Jan 8, 27
▲ Overweight · 🎯$265
Price at call : $227.24 — upside +17%
Today : $208.23 — upside +27%
🎯 on IQV : 0% (1 call matured) · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Dec 2, 26
BMO Capital
Nov 13, 25
▲ Outperform · 🎯$260
Price at call : $223.55 — upside +16%
Today : $208.23 — upside +25%
🎯 on IQV : no call matured yet · 📊 on Health : 60.9% · +9.2% (235 calls)
in progress (365j)
matures : Nov 13, 26
TD Cowen
Nov 3, 25
■ Hold neutral · not a buy · 🎯$215
Price at call : $210.96 — gap to target +2%
Today : $208.23 — gap to target +3%
🎯 on IQV : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Nov 3, 26
Citigroup
Oct 29, 25
■ Neutral neutral · not a buy · 🎯$230
Price at call : $216.47 — gap to target +6%
Today : $208.23 — gap to target +10%
🎯 on IQV : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Oct 29, 26
UBS
Oct 29, 25
▲ Buy · 🎯$250
Price at call : $216.47 — upside +15%
Today : $208.23 — upside +20%
🎯 on IQV : 100% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Oct 29, 26
Stifel
Oct 29, 25
▲ Buy · 🎯$254
Price at call : $216.47 — upside +17%
Today : $208.23 — upside +22%
🎯 on IQV : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Oct 29, 26
▲ Buy · 🎯$265
Price at call : $216.47 — upside +22%
Today : $208.23 — upside +27%
🎯 on IQV : 25% (12 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Oct 29, 26
JP Morgan
Oct 29, 25
▲ Overweight · 🎯$255
Price at call : $216.47 — upside +18%
Today : $208.23 — upside +22%
🎯 on IQV : 50% (2 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Oct 29, 26
Baird
Oct 29, 25
▲ Outperform · 🎯$258
Price at call : $217.83 — upside +18%
Today : $208.23 — upside +24%
🎯 on IQV : no call matured yet · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Oct 29, 26
HSBC
Oct 9, 25
▲ Buy · 🎯$235
Price at call : $203 — upside +16%
Today : $208.23 — upside +13%
🎯 on IQV : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Oct 9, 26
▲ Outperform · 🎯$240
Price at call : $200.6 — upside +20%
Today : $208.23 — upside +15%
🎯 on IQV : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Oct 8, 26
Barclays
Oct 2, 25
■ Equal-Weight neutral · not a buy · 🎯$200
Price at call : $206.63 — gap to target -3%
Today : $208.23 — gap to target -4%
🎯 on IQV : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Oct 2, 26
Jefferies
Sep 9, 25
▲ Buy · 🎯$225
Price at call : $189.64 — upside +19%
Today : $208.23 — upside +8%
🎯 on IQV : no call matured yet · 📊 on Health : 50.5% · +4.5% (376 calls)
in progress (365j)
matures : Sep 9, 26
Mizuho
Jul 25, 25
▲ Outperform · 🎯$225
Price at call : $197.76 — upside +14%
Today : $208.23 — upside +8%
🎯 on IQV : 100% (2 calls matureds) · 📊 on Health : 53.8% · +4.4% (208 calls)
in progress (365j)
matures : Jul 25, 26
Citigroup
Jul 23, 25
■ Neutral neutral · not a buy · 🎯$200
Price at call : $200.82 — gap to target -0%
Today : $208.23 — gap to target -4%
🎯 on IQV : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Jul 23, 26
UBS
Jul 23, 25
▲ Buy · 🎯$225
Price at call : $200.82 — upside +12%
Today : $208.23 — upside +8%
🎯 on IQV : 100% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Jul 23, 26
▲ Buy · 🎯$235
Price at call : $200.82 — upside +17%
Today : $208.23 — upside +13%
🎯 on IQV : 25% (12 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Jul 23, 26
Barclays
Jul 23, 25
■ Equal-Weight neutral · not a buy · 🎯$185
Price at call : $194.24 — gap to target -5%
Today : $208.23 — gap to target -11%
🎯 on IQV : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Jul 23, 26
Baird
Jul 23, 25
■ Neutral neutral · not a buy · 🎯$196
Price at call : $194.24 — gap to target +1%
Today : $208.23 — gap to target -6%
🎯 on IQV : no call matured yet · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Jul 23, 26
▲ Outperform · 🎯$180
Price at call : $162.02 — upside +11%
Today : $208.23 — upside -14%
🎯 on IQV : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Jul 9, 26
JP Morgan
May 19, 25
▲ Overweight · 🎯$177
Price at call : $144.95 — upside +22%
Today : $208.23 — upside -15%
Expected +22% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on IQV : 50% (2 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)
+18.3%
stock +18% · XLV +9%
Mizuho
May 15, 25
▲ Outperform · 🎯$190
Price at call : $142.82 — upside +33%
Today : $208.23 — upside -9%
Expected +33% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on IQV : 100% (2 calls matureds) · 📊 on Health : 53.8% · +4.4% (208 calls)
+21.0%
stock +21% · XLV +9%
Citigroup
May 7, 25
■ Neutral neutral · not a buy · 🎯$160
Price at call : $153.29 — gap to target +4%
Today : $208.23 — gap to target -23%
🎯 on IQV : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : May 7, 26
Baird
May 7, 25
■ Neutral neutral · not a buy · 🎯$161
Price at call : $153.29 — gap to target +5%
Today : $208.23 — gap to target -23%
🎯 on IQV : no call matured yet · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : May 7, 26
UBS
May 7, 25
▲ Buy · 🎯$185
Price at call : $153.29 — upside +21%
Today : $208.23 — upside -11%
Expected +21% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on IQV : 100% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
+16.6%
stock +17% · XLV +7%
Barclays
May 7, 25
■ Equal-Weight neutral · not a buy · 🎯$165
Price at call : $153.3 — gap to target +8%
Today : $208.23 — gap to target -21%
🎯 on IQV : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : May 7, 26
HSBC
Apr 25, 25
■ Hold neutral · not a buy · 🎯$160
Price at call : $150.13 — gap to target +7%
Today : $208.23 — gap to target -23%
🎯 on IQV : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Apr 25, 26
▲ Buy · 🎯$216
Price at call : $143.22 — upside +51%
Today : $208.23 — upside +4%
Expected +51% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on IQV : 25% (12 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
+16.8%
stock +17% · XLV +9%
Barclays
Apr 10, 25
■ Equal-Weight neutral · not a buy · 🎯$170
Price at call : $143.22 — gap to target +19%
Today : $208.23 — gap to target -18%
🎯 on IQV : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Apr 10, 26
Mizuho
Apr 9, 25
▲ Outperform · 🎯$210
Price at call : $157.02 — upside +34%
Today : $208.23 — upside +1%
Expected +34% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 100% (2 calls matureds) · 📊 on Health : 53.8% · +4.4% (208 calls)
+7.6%
stock +8% · XLV +8%
Citigroup
Mar 4, 25
■ Neutral neutral · not a buy · 🎯$210
Price at call : $185.85 — gap to target +13%
Today : $208.23 — gap to target +1%
🎯 on IQV : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Mar 4, 26
JP Morgan
Feb 18, 25
▲ Overweight · 🎯$232
Price at call : $196.51 — upside +18%
Today : $208.23 — upside +11%
Expected +18% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 50% (2 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)
-13.8%
stock -14% · XLV +7%
▲ Overweight · 🎯$250
Price at call : $197.82 — upside +26%
Today : $208.23 — upside +20%
Expected +26% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 0% (1 call matured) · 📊 on Health : 51.7% · +5.3% (804 calls)
-14.6%
stock -15% · XLV +7%
RBC Capital
Feb 10, 25
▲ Outperform · 🎯$270
Price at call : $200.89 — upside +34%
Today : $208.23 — upside +30%
Expected +34% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 0% (1 call matured) · 📊 on Health : 43% · -1.9% (381 calls)
-11.8%
stock -12% · XLV +7%
▲ Buy · 🎯$263
Price at call : $206.97 — upside +27%
Today : $208.23 — upside +26%
Expected +27% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 25% (12 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
-11.8%
stock -12% · XLV +6%
▲ Buy · 🎯$261
Price at call : $199.06 — upside +31%
Today : $208.23 — upside +25%
Expected +31% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 25% (12 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
+12.3%
stock +12% · XLV +11%
▲ Outperform · 🎯$248
Price at call : $194.38 — upside +28%
Today : $208.23 — upside +19%
Expected +28% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 100% (1 call matured) · 📊 on Health : 57.1% · +6.2% (35 calls)
+11.7%
stock +12% · XLV +6%
▲ Buy · 🎯$265
Price at call : $212.87 — upside +24%
Today : $208.23 — upside +27%
Expected +24% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 25% (12 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
-1.3%
stock -1% · XLV -1%
▲ Buy · 🎯$286
Price at call : $232.98 — upside +23%
Today : $208.23 — upside +37%
Expected +23% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 25% (12 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
-12.8%
stock -13% · XLV -7%
▲ Buy · 🎯$300
Price at call : $238.75 — upside +26%
Today : $208.23 — upside +44%
Expected +26% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 25% (12 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
-15.9%
stock -16% · XLV -9%
▲ Buy · 🎯$292
Price at call : $227.04 — upside +29%
Today : $208.23 — upside +40%
Expected +29% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 25% (12 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
-32.9%
stock -33% · XLV -2%
▲ Buy · 🎯$297
Price at call : $248.84 — upside +19%
Today : $208.23 — upside +43%
Expected +19% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 25% (12 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
-23.3%
stock -23% · XLV +1%
▲ Buy · 🎯$286
Price at call : $220.52 — upside +30%
Today : $208.23 — upside +37%
Expected +30% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 25% (12 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
-9.6%
stock -10% · XLV -0%
▲ Buy · 🎯$240
Price at call : $209.52 — upside +15%
Today : $208.23 — upside +15%
Expected +15% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on IQV : 25% (12 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
-5.7%
stock -6% · XLV +10%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)